Exagen Inc. (FRA:E08A)

Exagen Statistics

Total Valuation

Exagen has a market cap or net worth of EUR 146.21 million. The enterprise value is 139.77 million.

Market Cap	146.21M
Enterprise Value	139.77M

Important Dates

The next estimated earnings date is Monday, March 16, 2026.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.66M
Shares Outstanding	n/a
Shares Change (YoY)	+12.25%
Shares Change (QoQ)	+8.80%
Owned by Insiders (%)	4.73%
Owned by Institutions (%)	36.36%
Float	14.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.70
PB Ratio	9.46
P/TBV Ratio	9.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.61
EV / Sales	2.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.92

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 1.55.

Current Ratio	4.08
Quick Ratio	3.63
Debt / Equity	1.55
Debt / EBITDA	n/a
Debt / FCF	-2.56
Interest Coverage	-3.51

Financial Efficiency

Return on equity (ROE) is -122.81% and return on invested capital (ROIC) is -18.81%.

Return on Equity (ROE)	-122.81%
Return on Assets (ROA)	-14.66%
Return on Invested Capital (ROIC)	-18.81%
Return on Capital Employed (ROCE)	-24.99%
Revenue Per Employee	255,686
Profits Per Employee	-76,542
Employee Count	215
Asset Turnover	1.20
Inventory Turnover	7.90

Taxes

In the past 12 months, Exagen has paid 42,615 in taxes.

Income Tax	42,615
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+77.03%
50-Day Moving Average	8.76
200-Day Moving Average	6.43
Relative Strength Index (RSI)	21.13
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, Exagen had revenue of EUR 54.21 million and -16.23 million in losses. Loss per share was -0.80.

Revenue	54.21M
Gross Profit	32.45M
Operating Income	-10.63M
Pretax Income	-16.18M
Net Income	-16.23M
EBITDA	-8.99M
EBIT	-10.63M
Loss Per Share	-0.80

Balance Sheet

The company has 30.39 million in cash and 24.01 million in debt, giving a net cash position of 6.38 million.

Cash & Cash Equivalents	30.39M
Total Debt	24.01M
Net Cash	6.38M
Net Cash Per Share	n/a
Equity (Book Value)	15.46M
Book Value Per Share	0.69
Working Capital	33.84M

Cash Flow

In the last 12 months, operating cash flow was -8.74 million and capital expenditures -633,259, giving a free cash flow of -9.37 million.

Operating Cash Flow	-8.74M
Capital Expenditures	-633,259
Free Cash Flow	-9.37M
FCF Per Share	n/a

Margins

Gross margin is 59.86%, with operating and profit margins of -19.62% and -29.94%.

Gross Margin	59.86%
Operating Margin	-19.62%
Pretax Margin	-29.86%
Profit Margin	-29.94%
EBITDA Margin	-16.58%
EBIT Margin	-19.62%
FCF Margin	n/a

Dividends & Yields

Exagen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.25%
Shareholder Yield	-12.25%
Earnings Yield	-11.10%
FCF Yield	-6.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exagen has an Altman Z-Score of -4.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.27
Piotroski F-Score	4